SlideShare a Scribd company logo
1 of 19
THE USE OF OPIOIDS IN PAIN MANAGEMENT
Dr. Antony L. Yiaile
Consultant Pharmacist and Lecturer of Clinical
Pharmacology & Toxicology
Department of Clinical Medicine University of
Kabianga
Kericho County Kenya
Introduction
 Pain is one of the oldest medical challenges facing humankind.
 It has long history in medicine, religion, and social science.
 Unfortunately, there is lack of detailed information on contemporary,
patient-centered approach to understand and manage acute and
chronic pain.
 This knowledge gap in pain management is leading to ineffective and
counterproductive pain management strategies (Sabatowski et al
2004).
 Therefore, there is the need for better our understanding on
contemporary, patient-centered approaches on pain management.
Use of Opioids in Pain Management
 Opioid use in pain management dates back to the 1800s.
 The use of opioids increased because of the need to treat
serious injuries sustained in warfare.
 Advancements in pain physiology, the discovery of endogenous
endorphins and opioid receptors, and the development of
synthetic opioids greatly influenced its use.
 By nature, it is extracted from opium poppy plant and functions in
the brain to relief pain and bring about relaxation.
 What are we using in the healthcare?
 The natural forms such as Morphine Codeine
 Semi-synthetic forms such as Oxycodone and Meperidine
 Fully synthetic forms such as Fentanyl and Methadone
Medical vs Non-medical opioid users
Medical users Non-medical users
They take opioids for the
prescribed use (for pain relief)
with no extra doses for pain
relief or pleasurable effect
 It is illicit,
 Taken in manner other than
the one prescribed by a
physician.
 Given by or stolen from family
or friends, Doctor shopping,
bought from drug dealers
Concern: risk of dependence goes up
with amount and length of treatment
How Opioids Work to Manage Pain
 First, they attach themselves to and activate opioid receptors on
nerve cells in the brain, spinal cord, gut and other parts of the
body especially those that feel pain and pleasure.
 When this happens, they block pain messages sent from the
body through the spinal cord to the brain thus managing pain.
 Although they can effectively relieve pain, they carry some risks
and can be highly addictive.
 The risk of addiction present when they are used in the
management of chronic pain over a long period of time.
tTerminologies used in opioid therapy
 Opioids: Drugs that bind to opioid receptors which are found principally in the central nervous system and the gastrointestinal
tract
 Narcotic:This is a term derived from the Greek word “stupor” and it originally referred to any drug that induced sleep but is
now associated with opioids.
 Tolerance: refers to a decrease in effectiveness of a drug with its repeated administration and an increased dose is required to
produce the same physiological response.
 Dependence: refers to a complex set of changes in the homeostasis of an organism that causes a disturbance of the homeostatic
set point of the organism if the drug is stopped.
 Withdrawal: is the unpleasant, sometimes life-threatening physiological changes that occur due to the discontinuation of use of
some drugs after prolonged regular use. In the case of opioids signs of withdrawal include chills, fever, sweating, yawning,
vomiting, diarrhea, nausea, dizziness and hypertension.
 Addiction/Substance abuse: refers to dependence on a habit forming substance or behavior that the person is powerless
 to stop. There are two types of addictions:
 Substance addictions e.g. alcoholism, drug abuse, smoking.
 Process addiction e.g. gambling, spending,shopping, eating e.t.c
Opioid Receptors and Neurological Responses
 Individual opioid receptors have unique neurological feedback.
 Each opioid has a different binding affinity for the different types of opioid
receptors.
 Three classical types of opioid receptors include
(a) μ (Mu),
(b) κ (Kappa)
(c) δ (delta).
 μ (Mu) Opioid Receptors
 They are found in the thalamus and brainstem.
 Its three subtypes include μ1, μ2 and μ3 receptors
 Activation of subtypes brings about pain alleviation, euphoria , sedation and
respiratory depression
Cont..
 The Kappa Opioid Receptors
 They are found in the spinal cord, brainstem and the limbic system.
 As this receptor is activated, it induces pain relief, sedation, shortness
of breath, and dependency.
 The delta Opioid Receptors
 They are distributed in the spinal cord, digestive tract and the brain.
 This receptor's stimulation has analgesic and antidepressant benefits,
but it may also induce respiratory distress.
PHARMACOLOGICAL EFFECTS OF OPIODS
i. Analgesia
ii. Medullary Effects
iii. Hypothalamic Effects
iv. Neuroendocrine Effects
v. Convulsions
i. GI Effects
ii. Effects on the Skin
iii. Immune Function and Histamine
iv. Cardiovascular Effects
v. Antitussive Effects
vi. Tolerance and Physical Dependence
Opioid Analgesics
Classification Example FDA-approved indications
MIXED OPIOID AGONIST–
ANTAGONISTS OR PARTIAL
AGONISTS
OPIOID ANTAGONISTS
Pentazocine
Butorphanol
Nalbuphine
Buprenorphine
Naloxone
Naltrexone
Nalmefene
Relied of moderate to severe
pain
Pure antagonists
MORPHINE AND RELATED
OPIOID AGONISTS
MORPHINE
CODEINE AND OTHER
PHENANTHRENE
DERIVATIVES
MEPERIDINE AND RELATED
PHENYLPIPERIDINE
DERIVATIVES
Relief of moderate to severe
acute pain
Relief of moderate to
moderately severe chronic
pain in patients requiring
Considerations for opioid use
 There are many opioids and opioid combination products each with its own
treatment uses.
 Therefore it’s crucial to use the right opioid and use it correctly.
 Factors to consider before choosing the best opioid product(s) for an individual
treatment include;-
 Age
This is because not all opioid products are appropriate for all age groups.
 Severity of the pain
Some opioids medications are stronger than others. For example, codeine-
acetaminophen, are only used for mild to moderate pain.
 Pain treatment history,
Some opioids such as fentanyl and methadone are only appropriate for those
already taking the drug and in need of long-term therapy.
Cont..
 Other conditions that you may have
Kidneys are involved in removal of some opioid medications from body,
therefore, poorly functioning kidney may expose one to the side effects
of some opioids such as codeine, morphine etc
 Other drugs you take
Some drugs may interact antagonistically with certain opioids
 History of substance use disorders
Some opioids such as Embeda and Targiniq ER are designed to
reduce the risk of misuse.
Opioid complications and side effects
 Healthcare professional need to manage pain medications so closely
because of some complications and side effects.
 Abuse and diversion of opioids is becoming a challenge as their
availability increases chances of miususe (Ricardo Buenaventura et al
2008)
 Opioids have been found to decrease total sleep time and sleep
efficiency (Kurz & Sessler, 2003).
 The risk of opioid-induced bladder dysfunction (i.e., difficulty voiding or
frank urinary retention) (Ricardo Buenaventura et al 2008).
 Opioid-induced cardiac adverse events such as hypotension (Ricardo
Buenaventura et al 2008).
Opioid-induced hormonal changes
Hormone Opioid Effect Potential symptom linkage
Testosterone Decrease Decreased libido, erectile dysfunction &
reduced energy
Estrogen Decrease Sexual dysfunction, reduced bone mineral
density, osteoporosis
Cortisol Decrease Secondary hormonal alterations
Luetenizing hormone Decrease Secondary reduced androgen hormone levels,
Amenorrhea, hypomenorrhea
Gonadotropin releasing
hormone
Decrease secondary reduced androgen hormone levels
Opioid Receptor Effect
mu opioid receptor Decreases NK cell activity (central)
Macrophage phagocytosis (central)
Inhibits T-cell proliferation (central)
Nitric oxide release (peripheral)
delta opioid receptor Increases NK cell activity (central)
Potentiates humoral immune response
(MOR dependent)
Decreases PFC response
kappa opioid receptor Pronounced suppression of humoral
immunity
N.K=natural killer
PFC=plaque forming cells
Central immunologic effects of opioids
Opioid-induced Constipation
 Constipation is a common effect to 40% to 95% of patients treated with
opioids even with a single dose of morphine (Swegle and Logemann,
2006).
 Although constipation may be seen as a minor effect, long-term
consequences can lead to high morbidity and mortality (Ricardo
Buenaventura et al 2008).
 There is a need for effective treatment of opiate-induced constipation
Medical agent Formula/strength Adult dosage Side effect/complication
Polycarbophil(Fibercon) Tablets: 625 mg 2 tabs 1 to 4
times daily
Increased intestinal gas.
Lactulose Liquid: 10 g per 15 mL 15 to 60 mL daily Flatulence, diarrhea, nausea
or vomiting.
Tegaserod (Zelnorm) Tablets: 2 mg, 6 mg 2 times daily headache, abdominal pain,
and diarrhea
Strategies to Prevent Opioid Use Disorder
 Establishment of prescription drug monitoring programs
 Sensitization on the risks of prescription opioids and the cost of
overdose on patients.
 Educating patients on the safe storage and disposal of prescription
opioid.
 Educating providers on opioid prescribing guidelines
 Quality improvement programs to increase implementation of
recommended prescribing practices
 Enactment of drug prescription laws
END
References
Sabatowski, R., Schafer, D., Kasper, S. M., Brunsch, H., & Radbruch, L.
(2004). Pain treatment: a historical overview. Current pharmaceutical design,
10(7), 701-716.
Ricardo Buenaventura, M., Rajive Adlaka, M., & Nalini Sehgal, M. (2008).
Opioid complications and side effects. Pain physician, 11, S105-S120.
Kurz, A., & Sessler, D. I. (2003). Opioid-induced bowel dysfunction. Drugs,
63(7), 649-671.
Swegle, J. M., & Logemann, C. D. (2006). Management of common opioid-
induced adverse effects. American family physician, 74(8), 1347-1354.

More Related Content

Similar to lec 7b Use of Opioids in Pain Management.pptx

Meds For Pain And Inflammation
Meds For Pain And InflammationMeds For Pain And Inflammation
Meds For Pain And Inflammation
pmrjulio
 
3978 S1 04 Lipman
3978 S1 04 Lipman3978 S1 04 Lipman
3978 S1 04 Lipman
jamal53
 
paindrugs-121015233648-phpapp01.pdf
paindrugs-121015233648-phpapp01.pdfpaindrugs-121015233648-phpapp01.pdf
paindrugs-121015233648-phpapp01.pdf
JehanHadjiusman4
 

Similar to lec 7b Use of Opioids in Pain Management.pptx (20)

CHRONIC PAIN ----Management Update.ppt
CHRONIC  PAIN ----Management  Update.pptCHRONIC  PAIN ----Management  Update.ppt
CHRONIC PAIN ----Management Update.ppt
 
Opioid analgesics
Opioid analgesicsOpioid analgesics
Opioid analgesics
 
Pain and Opioid (narcotic) analgesics
Pain and Opioid (narcotic) analgesicsPain and Opioid (narcotic) analgesics
Pain and Opioid (narcotic) analgesics
 
The dark side of opioids
The dark side of opioidsThe dark side of opioids
The dark side of opioids
 
The dark side_of_opioids_in_pain_management__.3
The dark side_of_opioids_in_pain_management__.3The dark side_of_opioids_in_pain_management__.3
The dark side_of_opioids_in_pain_management__.3
 
Psychopharmacology.knk
Psychopharmacology.knkPsychopharmacology.knk
Psychopharmacology.knk
 
Opioids
OpioidsOpioids
Opioids
 
The GP's practice emergency aid delivery in a case of pain syndrome
The GP's practice emergency aid delivery in a case of pain syndromeThe GP's practice emergency aid delivery in a case of pain syndrome
The GP's practice emergency aid delivery in a case of pain syndrome
 
Pain drugs
Pain drugsPain drugs
Pain drugs
 
Basics of analgesic drugs
Basics of analgesic drugsBasics of analgesic drugs
Basics of analgesic drugs
 
Opioid Analgesics
Opioid AnalgesicsOpioid Analgesics
Opioid Analgesics
 
Opioid-Analgesics-Effective-Pain-Relief-with-Caution (1).pptx
Opioid-Analgesics-Effective-Pain-Relief-with-Caution (1).pptxOpioid-Analgesics-Effective-Pain-Relief-with-Caution (1).pptx
Opioid-Analgesics-Effective-Pain-Relief-with-Caution (1).pptx
 
Non narcotic: Agonist antagonist
Non narcotic: Agonist antagonistNon narcotic: Agonist antagonist
Non narcotic: Agonist antagonist
 
Analgesics in Dentistry
Analgesics in DentistryAnalgesics in Dentistry
Analgesics in Dentistry
 
Chp no 4 Drugs affecting pain & inflammation - NSAIDs.pptx
Chp no 4 Drugs affecting pain & inflammation - NSAIDs.pptxChp no 4 Drugs affecting pain & inflammation - NSAIDs.pptx
Chp no 4 Drugs affecting pain & inflammation - NSAIDs.pptx
 
Meds For Pain And Inflammation
Meds For Pain And InflammationMeds For Pain And Inflammation
Meds For Pain And Inflammation
 
Opioids analgesics medichem i
Opioids analgesics medichem iOpioids analgesics medichem i
Opioids analgesics medichem i
 
3978 S1 04 Lipman
3978 S1 04 Lipman3978 S1 04 Lipman
3978 S1 04 Lipman
 
Adventures in Pharmacopalliation: Cancer Pain Management
Adventures in Pharmacopalliation: Cancer Pain ManagementAdventures in Pharmacopalliation: Cancer Pain Management
Adventures in Pharmacopalliation: Cancer Pain Management
 
paindrugs-121015233648-phpapp01.pdf
paindrugs-121015233648-phpapp01.pdfpaindrugs-121015233648-phpapp01.pdf
paindrugs-121015233648-phpapp01.pdf
 

More from KipronoKeitanyTimoth

More from KipronoKeitanyTimoth (20)

puerperal_sepsis.pptx
puerperal_sepsis.pptxpuerperal_sepsis.pptx
puerperal_sepsis.pptx
 
PHARMACOLOGY ASSIGNMENT.pptx
PHARMACOLOGY ASSIGNMENT.pptxPHARMACOLOGY ASSIGNMENT.pptx
PHARMACOLOGY ASSIGNMENT.pptx
 
Drug development during clinical trials.pptx
Drug development during clinical trials.pptxDrug development during clinical trials.pptx
Drug development during clinical trials.pptx
 
TYPHOID FEVER.& Other T. Diseases..pptx
TYPHOID FEVER.& Other T. Diseases..pptxTYPHOID FEVER.& Other T. Diseases..pptx
TYPHOID FEVER.& Other T. Diseases..pptx
 
lec 5 NERVOUS SYSTEM_SYNAPSES_PPT_AKUNGA.pptx
lec 5 NERVOUS SYSTEM_SYNAPSES_PPT_AKUNGA.pptxlec 5 NERVOUS SYSTEM_SYNAPSES_PPT_AKUNGA.pptx
lec 5 NERVOUS SYSTEM_SYNAPSES_PPT_AKUNGA.pptx
 
EXCRETION OF DRUGS.pptx
EXCRETION OF DRUGS.pptxEXCRETION OF DRUGS.pptx
EXCRETION OF DRUGS.pptx
 
lec 1,2,3 physiology of pregnancy .pptx
lec 1,2,3 physiology of pregnancy .pptxlec 1,2,3 physiology of pregnancy .pptx
lec 1,2,3 physiology of pregnancy .pptx
 
NSAIDs.pptx
NSAIDs.pptxNSAIDs.pptx
NSAIDs.pptx
 
lec 7 Cushing's syndrome.pptx
lec 7 Cushing's syndrome.pptxlec 7 Cushing's syndrome.pptx
lec 7 Cushing's syndrome.pptx
 
INTRODUCTION TO CNS DRUGS.pptx
INTRODUCTION TO CNS DRUGS.pptxINTRODUCTION TO CNS DRUGS.pptx
INTRODUCTION TO CNS DRUGS.pptx
 
Z-L13- B123-Cavities Embryology & Disorders.pptx
Z-L13- B123-Cavities Embryology & Disorders.pptxZ-L13- B123-Cavities Embryology & Disorders.pptx
Z-L13- B123-Cavities Embryology & Disorders.pptx
 
ANTIMYCOBACTERIALS.pptx
ANTIMYCOBACTERIALS.pptxANTIMYCOBACTERIALS.pptx
ANTIMYCOBACTERIALS.pptx
 
MENSTRUAL DISORDERS RHI.pptx
MENSTRUAL DISORDERS RHI.pptxMENSTRUAL DISORDERS RHI.pptx
MENSTRUAL DISORDERS RHI.pptx
 
NEUROENDOCRINE MEDICINE.pptx
NEUROENDOCRINE MEDICINE.pptxNEUROENDOCRINE MEDICINE.pptx
NEUROENDOCRINE MEDICINE.pptx
 
DOC-20230301-WA0023..pptx
DOC-20230301-WA0023..pptxDOC-20230301-WA0023..pptx
DOC-20230301-WA0023..pptx
 
Antimicrobials -3 final.pptx
Antimicrobials -3 final.pptxAntimicrobials -3 final.pptx
Antimicrobials -3 final.pptx
 
Z-L5-B227-Anaemia & Haemoglobinopathies.pptx
Z-L5-B227-Anaemia & Haemoglobinopathies.pptxZ-L5-B227-Anaemia & Haemoglobinopathies.pptx
Z-L5-B227-Anaemia & Haemoglobinopathies.pptx
 
4 Bone Metabolism.pptx
4 Bone Metabolism.pptx4 Bone Metabolism.pptx
4 Bone Metabolism.pptx
 
antimicrobials -1.pptx
antimicrobials -1.pptxantimicrobials -1.pptx
antimicrobials -1.pptx
 
PARKINSON'S DISEASE.pptx
PARKINSON'S DISEASE.pptxPARKINSON'S DISEASE.pptx
PARKINSON'S DISEASE.pptx
 

Recently uploaded

Jual Obat Aborsi Di Dubai UAE Wa 0838-4800-7379 Obat Penggugur Kandungan Cytotec
Jual Obat Aborsi Di Dubai UAE Wa 0838-4800-7379 Obat Penggugur Kandungan CytotecJual Obat Aborsi Di Dubai UAE Wa 0838-4800-7379 Obat Penggugur Kandungan Cytotec
Jual Obat Aborsi Di Dubai UAE Wa 0838-4800-7379 Obat Penggugur Kandungan Cytotec
jualobat34
 
Physiologic Anatomy of Heart_AntiCopy.pdf
Physiologic Anatomy of Heart_AntiCopy.pdfPhysiologic Anatomy of Heart_AntiCopy.pdf
Physiologic Anatomy of Heart_AntiCopy.pdf
MedicoseAcademics
 
Difference Between Skeletal Smooth and Cardiac Muscles
Difference Between Skeletal Smooth and Cardiac MusclesDifference Between Skeletal Smooth and Cardiac Muscles
Difference Between Skeletal Smooth and Cardiac Muscles
MedicoseAcademics
 

Recently uploaded (20)

ABO Blood grouping in-compatibility in pregnancy
ABO Blood grouping in-compatibility in pregnancyABO Blood grouping in-compatibility in pregnancy
ABO Blood grouping in-compatibility in pregnancy
 
Jual Obat Aborsi Di Dubai UAE Wa 0838-4800-7379 Obat Penggugur Kandungan Cytotec
Jual Obat Aborsi Di Dubai UAE Wa 0838-4800-7379 Obat Penggugur Kandungan CytotecJual Obat Aborsi Di Dubai UAE Wa 0838-4800-7379 Obat Penggugur Kandungan Cytotec
Jual Obat Aborsi Di Dubai UAE Wa 0838-4800-7379 Obat Penggugur Kandungan Cytotec
 
Top 10 Most Beautiful Chinese Pornstars List 2024
Top 10 Most Beautiful Chinese Pornstars List 2024Top 10 Most Beautiful Chinese Pornstars List 2024
Top 10 Most Beautiful Chinese Pornstars List 2024
 
Face and Muscles of facial expression.pptx
Face and Muscles of facial expression.pptxFace and Muscles of facial expression.pptx
Face and Muscles of facial expression.pptx
 
Physiologic Anatomy of Heart_AntiCopy.pdf
Physiologic Anatomy of Heart_AntiCopy.pdfPhysiologic Anatomy of Heart_AntiCopy.pdf
Physiologic Anatomy of Heart_AntiCopy.pdf
 
TEST BANK For Porth's Essentials of Pathophysiology, 5th Edition by Tommie L ...
TEST BANK For Porth's Essentials of Pathophysiology, 5th Edition by Tommie L ...TEST BANK For Porth's Essentials of Pathophysiology, 5th Edition by Tommie L ...
TEST BANK For Porth's Essentials of Pathophysiology, 5th Edition by Tommie L ...
 
Difference Between Skeletal Smooth and Cardiac Muscles
Difference Between Skeletal Smooth and Cardiac MusclesDifference Between Skeletal Smooth and Cardiac Muscles
Difference Between Skeletal Smooth and Cardiac Muscles
 
Physicochemical properties (descriptors) in QSAR.pdf
Physicochemical properties (descriptors) in QSAR.pdfPhysicochemical properties (descriptors) in QSAR.pdf
Physicochemical properties (descriptors) in QSAR.pdf
 
Part I - Anticipatory Grief: Experiencing grief before the loss has happened
Part I - Anticipatory Grief: Experiencing grief before the loss has happenedPart I - Anticipatory Grief: Experiencing grief before the loss has happened
Part I - Anticipatory Grief: Experiencing grief before the loss has happened
 
Cardiac Output, Venous Return, and Their Regulation
Cardiac Output, Venous Return, and Their RegulationCardiac Output, Venous Return, and Their Regulation
Cardiac Output, Venous Return, and Their Regulation
 
7 steps How to prevent Thalassemia : Dr Sharda Jain & Vandana Gupta
7 steps How to prevent Thalassemia : Dr Sharda Jain & Vandana Gupta7 steps How to prevent Thalassemia : Dr Sharda Jain & Vandana Gupta
7 steps How to prevent Thalassemia : Dr Sharda Jain & Vandana Gupta
 
ANATOMY AND PHYSIOLOGY OF REPRODUCTIVE SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF REPRODUCTIVE SYSTEM.pptxANATOMY AND PHYSIOLOGY OF REPRODUCTIVE SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF REPRODUCTIVE SYSTEM.pptx
 
VIP ℂall Girls Kothanur {{ Bangalore }} 6378878445 WhatsApp: Me 24/7 Hours Se...
VIP ℂall Girls Kothanur {{ Bangalore }} 6378878445 WhatsApp: Me 24/7 Hours Se...VIP ℂall Girls Kothanur {{ Bangalore }} 6378878445 WhatsApp: Me 24/7 Hours Se...
VIP ℂall Girls Kothanur {{ Bangalore }} 6378878445 WhatsApp: Me 24/7 Hours Se...
 
Test bank for critical care nursing a holistic approach 11th edition morton f...
Test bank for critical care nursing a holistic approach 11th edition morton f...Test bank for critical care nursing a holistic approach 11th edition morton f...
Test bank for critical care nursing a holistic approach 11th edition morton f...
 
Dr. A Sumathi - LINEARITY CONCEPT OF SIGNIFICANCE.pdf
Dr. A Sumathi - LINEARITY CONCEPT OF SIGNIFICANCE.pdfDr. A Sumathi - LINEARITY CONCEPT OF SIGNIFICANCE.pdf
Dr. A Sumathi - LINEARITY CONCEPT OF SIGNIFICANCE.pdf
 
MOTION MANAGEMANT IN LUNG SBRT BY DR KANHU CHARAN PATRO
MOTION MANAGEMANT IN LUNG SBRT BY DR KANHU CHARAN PATROMOTION MANAGEMANT IN LUNG SBRT BY DR KANHU CHARAN PATRO
MOTION MANAGEMANT IN LUNG SBRT BY DR KANHU CHARAN PATRO
 
Shazia Iqbal 2024 - Bioorganic Chemistry.pdf
Shazia Iqbal 2024 - Bioorganic Chemistry.pdfShazia Iqbal 2024 - Bioorganic Chemistry.pdf
Shazia Iqbal 2024 - Bioorganic Chemistry.pdf
 
Top 10 Most Beautiful Russian Pornstars List 2024
Top 10 Most Beautiful Russian Pornstars List 2024Top 10 Most Beautiful Russian Pornstars List 2024
Top 10 Most Beautiful Russian Pornstars List 2024
 
The Clean Living Project Episode 23 - Journaling
The Clean Living Project Episode 23 - JournalingThe Clean Living Project Episode 23 - Journaling
The Clean Living Project Episode 23 - Journaling
 
See it and Catch it! Recognizing the Thought Traps that Negatively Impact How...
See it and Catch it! Recognizing the Thought Traps that Negatively Impact How...See it and Catch it! Recognizing the Thought Traps that Negatively Impact How...
See it and Catch it! Recognizing the Thought Traps that Negatively Impact How...
 

lec 7b Use of Opioids in Pain Management.pptx

  • 1. THE USE OF OPIOIDS IN PAIN MANAGEMENT Dr. Antony L. Yiaile Consultant Pharmacist and Lecturer of Clinical Pharmacology & Toxicology Department of Clinical Medicine University of Kabianga Kericho County Kenya
  • 2. Introduction  Pain is one of the oldest medical challenges facing humankind.  It has long history in medicine, religion, and social science.  Unfortunately, there is lack of detailed information on contemporary, patient-centered approach to understand and manage acute and chronic pain.  This knowledge gap in pain management is leading to ineffective and counterproductive pain management strategies (Sabatowski et al 2004).  Therefore, there is the need for better our understanding on contemporary, patient-centered approaches on pain management.
  • 3. Use of Opioids in Pain Management  Opioid use in pain management dates back to the 1800s.  The use of opioids increased because of the need to treat serious injuries sustained in warfare.  Advancements in pain physiology, the discovery of endogenous endorphins and opioid receptors, and the development of synthetic opioids greatly influenced its use.  By nature, it is extracted from opium poppy plant and functions in the brain to relief pain and bring about relaxation.  What are we using in the healthcare?  The natural forms such as Morphine Codeine  Semi-synthetic forms such as Oxycodone and Meperidine  Fully synthetic forms such as Fentanyl and Methadone
  • 4. Medical vs Non-medical opioid users Medical users Non-medical users They take opioids for the prescribed use (for pain relief) with no extra doses for pain relief or pleasurable effect  It is illicit,  Taken in manner other than the one prescribed by a physician.  Given by or stolen from family or friends, Doctor shopping, bought from drug dealers Concern: risk of dependence goes up with amount and length of treatment
  • 5. How Opioids Work to Manage Pain  First, they attach themselves to and activate opioid receptors on nerve cells in the brain, spinal cord, gut and other parts of the body especially those that feel pain and pleasure.  When this happens, they block pain messages sent from the body through the spinal cord to the brain thus managing pain.  Although they can effectively relieve pain, they carry some risks and can be highly addictive.  The risk of addiction present when they are used in the management of chronic pain over a long period of time.
  • 6. tTerminologies used in opioid therapy  Opioids: Drugs that bind to opioid receptors which are found principally in the central nervous system and the gastrointestinal tract  Narcotic:This is a term derived from the Greek word “stupor” and it originally referred to any drug that induced sleep but is now associated with opioids.  Tolerance: refers to a decrease in effectiveness of a drug with its repeated administration and an increased dose is required to produce the same physiological response.  Dependence: refers to a complex set of changes in the homeostasis of an organism that causes a disturbance of the homeostatic set point of the organism if the drug is stopped.  Withdrawal: is the unpleasant, sometimes life-threatening physiological changes that occur due to the discontinuation of use of some drugs after prolonged regular use. In the case of opioids signs of withdrawal include chills, fever, sweating, yawning, vomiting, diarrhea, nausea, dizziness and hypertension.  Addiction/Substance abuse: refers to dependence on a habit forming substance or behavior that the person is powerless  to stop. There are two types of addictions:  Substance addictions e.g. alcoholism, drug abuse, smoking.  Process addiction e.g. gambling, spending,shopping, eating e.t.c
  • 7. Opioid Receptors and Neurological Responses  Individual opioid receptors have unique neurological feedback.  Each opioid has a different binding affinity for the different types of opioid receptors.  Three classical types of opioid receptors include (a) μ (Mu), (b) κ (Kappa) (c) δ (delta).  μ (Mu) Opioid Receptors  They are found in the thalamus and brainstem.  Its three subtypes include μ1, μ2 and μ3 receptors  Activation of subtypes brings about pain alleviation, euphoria , sedation and respiratory depression
  • 8. Cont..  The Kappa Opioid Receptors  They are found in the spinal cord, brainstem and the limbic system.  As this receptor is activated, it induces pain relief, sedation, shortness of breath, and dependency.  The delta Opioid Receptors  They are distributed in the spinal cord, digestive tract and the brain.  This receptor's stimulation has analgesic and antidepressant benefits, but it may also induce respiratory distress.
  • 9. PHARMACOLOGICAL EFFECTS OF OPIODS i. Analgesia ii. Medullary Effects iii. Hypothalamic Effects iv. Neuroendocrine Effects v. Convulsions i. GI Effects ii. Effects on the Skin iii. Immune Function and Histamine iv. Cardiovascular Effects v. Antitussive Effects vi. Tolerance and Physical Dependence
  • 10. Opioid Analgesics Classification Example FDA-approved indications MIXED OPIOID AGONIST– ANTAGONISTS OR PARTIAL AGONISTS OPIOID ANTAGONISTS Pentazocine Butorphanol Nalbuphine Buprenorphine Naloxone Naltrexone Nalmefene Relied of moderate to severe pain Pure antagonists MORPHINE AND RELATED OPIOID AGONISTS MORPHINE CODEINE AND OTHER PHENANTHRENE DERIVATIVES MEPERIDINE AND RELATED PHENYLPIPERIDINE DERIVATIVES Relief of moderate to severe acute pain Relief of moderate to moderately severe chronic pain in patients requiring
  • 11. Considerations for opioid use  There are many opioids and opioid combination products each with its own treatment uses.  Therefore it’s crucial to use the right opioid and use it correctly.  Factors to consider before choosing the best opioid product(s) for an individual treatment include;-  Age This is because not all opioid products are appropriate for all age groups.  Severity of the pain Some opioids medications are stronger than others. For example, codeine- acetaminophen, are only used for mild to moderate pain.  Pain treatment history, Some opioids such as fentanyl and methadone are only appropriate for those already taking the drug and in need of long-term therapy.
  • 12. Cont..  Other conditions that you may have Kidneys are involved in removal of some opioid medications from body, therefore, poorly functioning kidney may expose one to the side effects of some opioids such as codeine, morphine etc  Other drugs you take Some drugs may interact antagonistically with certain opioids  History of substance use disorders Some opioids such as Embeda and Targiniq ER are designed to reduce the risk of misuse.
  • 13. Opioid complications and side effects  Healthcare professional need to manage pain medications so closely because of some complications and side effects.  Abuse and diversion of opioids is becoming a challenge as their availability increases chances of miususe (Ricardo Buenaventura et al 2008)  Opioids have been found to decrease total sleep time and sleep efficiency (Kurz & Sessler, 2003).  The risk of opioid-induced bladder dysfunction (i.e., difficulty voiding or frank urinary retention) (Ricardo Buenaventura et al 2008).  Opioid-induced cardiac adverse events such as hypotension (Ricardo Buenaventura et al 2008).
  • 14. Opioid-induced hormonal changes Hormone Opioid Effect Potential symptom linkage Testosterone Decrease Decreased libido, erectile dysfunction & reduced energy Estrogen Decrease Sexual dysfunction, reduced bone mineral density, osteoporosis Cortisol Decrease Secondary hormonal alterations Luetenizing hormone Decrease Secondary reduced androgen hormone levels, Amenorrhea, hypomenorrhea Gonadotropin releasing hormone Decrease secondary reduced androgen hormone levels
  • 15. Opioid Receptor Effect mu opioid receptor Decreases NK cell activity (central) Macrophage phagocytosis (central) Inhibits T-cell proliferation (central) Nitric oxide release (peripheral) delta opioid receptor Increases NK cell activity (central) Potentiates humoral immune response (MOR dependent) Decreases PFC response kappa opioid receptor Pronounced suppression of humoral immunity N.K=natural killer PFC=plaque forming cells Central immunologic effects of opioids
  • 16. Opioid-induced Constipation  Constipation is a common effect to 40% to 95% of patients treated with opioids even with a single dose of morphine (Swegle and Logemann, 2006).  Although constipation may be seen as a minor effect, long-term consequences can lead to high morbidity and mortality (Ricardo Buenaventura et al 2008).  There is a need for effective treatment of opiate-induced constipation Medical agent Formula/strength Adult dosage Side effect/complication Polycarbophil(Fibercon) Tablets: 625 mg 2 tabs 1 to 4 times daily Increased intestinal gas. Lactulose Liquid: 10 g per 15 mL 15 to 60 mL daily Flatulence, diarrhea, nausea or vomiting. Tegaserod (Zelnorm) Tablets: 2 mg, 6 mg 2 times daily headache, abdominal pain, and diarrhea
  • 17. Strategies to Prevent Opioid Use Disorder  Establishment of prescription drug monitoring programs  Sensitization on the risks of prescription opioids and the cost of overdose on patients.  Educating patients on the safe storage and disposal of prescription opioid.  Educating providers on opioid prescribing guidelines  Quality improvement programs to increase implementation of recommended prescribing practices  Enactment of drug prescription laws
  • 18. END
  • 19. References Sabatowski, R., Schafer, D., Kasper, S. M., Brunsch, H., & Radbruch, L. (2004). Pain treatment: a historical overview. Current pharmaceutical design, 10(7), 701-716. Ricardo Buenaventura, M., Rajive Adlaka, M., & Nalini Sehgal, M. (2008). Opioid complications and side effects. Pain physician, 11, S105-S120. Kurz, A., & Sessler, D. I. (2003). Opioid-induced bowel dysfunction. Drugs, 63(7), 649-671. Swegle, J. M., & Logemann, C. D. (2006). Management of common opioid- induced adverse effects. American family physician, 74(8), 1347-1354.